stockrowGuardant Health, Inc.
GH Healthcare Diagnostics & Research
Guardant Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $982.0 million, up 32.9% from fiscal 2024.
- Revenue
- +36.1%
- EPS
- −25.7%
- Free cash flow
- +18.7%
- Total debt
- +34.8%
Quarter to September 2026, against a year earlier
Follow GH
Alert me
Guardant Health, Inc. (GH) Operating cash flow
Guardant Health, Inc.'s operating cash flow for fiscal 2025 was −$184.8M, compared with −$239.9M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$173.5M. Over the past ten years it has ranged from −$325.0M (fiscal 2023) to −$36.7M (fiscal 2016); the current reading is higher than 50% of that period. Guardant Health, Inc. ranks 48th of 49 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | −$184.8M | — |
| FY2024 | −$239.9M | — |
| FY2023 | −$325.0M | — |
| FY2022 | −$309.5M | — |
| FY2021 | −$209.0M | — |
| FY2020 | −$103.9M | — |
| FY2019 | −$47.1M | — |
| FY2018 | −$72.2M | — |
| FY2017 | −$72.2M | — |
| FY2016 | −$36.7M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | −$23.7M | — |
| Jun 2026 | −$57.8M | — |
| Mar 2026 | −$65.6M | — |
| Dec 2025 | −$26.4M | — |
| 34 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| DGX Quest Diagnostics Incorporated compare | $2.0B |
| LH Labcorp Holdings Inc. compare | $1.8B |
| ILMN Illumina, Inc. compare | $1.2B |
| ICLR ICON PLC compare | $1.0B |
| MTD Mettler-Toledo International, Inc. compare | $975.2M |
| MEDP Medpace Holdings, Inc. compare | $723.0M |
| RVTY Revvity Inc. compare | $655.8M |
| CRL Charles River Laboratories International, Inc. compare | $622.4M |
| GH Guardant Health, Inc. | −$173.5M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on GH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement